Kwality Pharmaceuticals Limited (BOM:539997)
India
· Delayed Price · Currency is INR | Market Cap | 16.73B |
| Revenue (ttm) | 4.62B |
| Net Income (ttm) | 565.34M |
| Shares Out | 10.38M |
| EPS (ttm) | 54.42 |
| PE Ratio | 29.62 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,756 |
| Average Volume | 25,440 |
| Open | 1,615.10 |
| Previous Close | 1,612.00 |
| Day's Range | 1,590.00 - 1,650.95 |
| 52-Week Range | 666.00 - 1,782.00 |
| Beta | 0.13 |
| RSI | 53.15 |
| Earnings Date | May 19, 2026 |
About Kwality Pharmaceuticals
Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally. The company offers its products in various dosage forms, including liquid orals, powder for oral suspension, dry syrups, tablets, capsules, sterile powder for injections, small volume parentals (liquid and lyophilized), pre filled syringes, ointments and creams, ophthalmic preparations, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized products, syrups, daunorubicin, an... [Read more]
Financial Performance
In fiscal year 2025, Kwality Pharmaceuticals's revenue was 3.70 billion, an increase of 20.52% compared to the previous year's 3.07 billion. Earnings were 398.45 million, an increase of 67.44%.
Financial StatementsNews
Kwality Pharma receives product registration for Bleomycin 15 IU per vial in Mexico
Kwality Pharmaceuticals Ltd has announced that it has received registration approval for Bleomycin 15 1U in Mexico, enabling the company to begin sales and distribution in the region. Bleomycin is a w...
Kwality Pharmaceuticals shares jump 17% after Q4 net profit surges 232% YoY
Shares of Kwality Pharmaceuticals surged 16.85% to ₹964.90 in early trade on Tuesday after the company posted a stellar set of numbers for the fourth quarter ended March 2025. The stock hit a high of ...
Kwality Pharmaceuticals receives GMP approval from SFDA for its two manufacturing units in Amritsar
Kwality Pharmaceuticals Limited has achieved a significant milestone by securing GMP (Good Manufacturing Practice) approval for its two audited manufacturing units in Amritsar. This prestigious certif...
Kwality Pharmaceuticals receives RCGM approval for pre-clinical studies of recombinant Erythropoietin
Kwality Pharmaceuticals Limited (KPL) announced a major milestone, securing approval from the Review Committee on Genetic Manipulation (RCGM) to advance pre-clinical toxicity studies for its recombina...
Kwality Pharmaceuticals gets SAHPRA approval in South Africa for Tamoxifen 20mg tablet
Kwality Pharmaceuticals Ltd. (KPL) proudly announces the approval of its oncology oral solid dosage (OSD) product, Tamoxifen 20mg Tablet, by the South African Health Products Regulatory Authority (SAH...